These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. High efficiency transduction of human VEGF165 into human skeletal myoblasts: in vitro studies. Ye L, Haider HKh, Jiang S, Ge R, Law PK, Sim EK. Exp Mol Med; 2003 Oct 31; 35(5):412-20. PubMed ID: 14646595 [Abstract] [Full Text] [Related]
8. Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector. Byun J, Heard JM, Huh JE, Park SJ, Jung EA, Jeong JO, Gwon HC, Kim DK. J Mol Cell Cardiol; 2001 Feb 31; 33(2):295-305. PubMed ID: 11162134 [Abstract] [Full Text] [Related]
12. VEGF165 and angiopoietin-1 decreased myocardium infarct size through phosphatidylinositol-3 kinase and Bcl-2 pathways. Zhou L, Ma W, Yang Z, Zhang F, Lu L, Ding Z, Ding B, Ha T, Gao X, Li C. Gene Ther; 2005 Feb 31; 12(3):196-202. PubMed ID: 15510173 [Abstract] [Full Text] [Related]
16. Assessment of the biological activity of an improved naked-DNA vector for angiogenesis gene therapy on a novel non-mammalian model. Perletti G, Marras E, Dondi D, Grimaldi A, Tettamanti G, Valvassori R, De Eguileor M. Int J Mol Med; 2003 Jun 31; 11(6):691-6. PubMed ID: 12736708 [Abstract] [Full Text] [Related]
17. Bone marrow-derived stem cell interactions with adult cardiomyocytes and skeletal myoblasts in vitro. Baffour R, Pakala R, Hellinga D, Joner M, Okubagzi P, Epstein SE, Waksman R. Cardiovasc Revasc Med; 2006 Jun 31; 7(4):222-30. PubMed ID: 17174868 [Abstract] [Full Text] [Related]